glp-1 shortage news today november 2025 trends 2025: real-world data, patient outcomes & future therapies National Hispanic Medical Association |

We can help you create the perfect treatment combination for your goals.

Chronic kidney disease in the United States, 2019

The risk: similar to PPIs, they lower stomach acid and reduce absorption, though the effect is typically milder

Research shows that overexpression of PER1 sensitizes human cancer cells to the effects of DNA damage-induced apoptosis

Key features of the current landscape: Academic and biotech interest has advanced the compound from early preclinical to translational work Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice

Furthermore, patients treated with the dual GLP-1R and GIP agonist tirzepatide exhibited lower Food Craving Inventory scores for sweets and high-fat fast foods compared to those receiving liraglutide, indicating a greater reduction in desire for these items during weight loss (Martin et al., 2025)